Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0207


Monitoring EGFR plasma levels: Is it a biomarker for colorectal cancer?

Eugenia Halkia, MD

Affiliation: Eugenia Halkia, Department of Gynaecology, "METAXA" Cancer Memorial Hospital, Botosi 51, TK 18535, Piraeus, Greece.


Since there is no abstract available we provide the first paragraph.

Although the EGFR signaling pathways regulates crucial cellular processes including cell proliferation, survival, differentiation, and apoptosis, no evidence exists that EGFR measurement in blood of cancer patients could be used as biomarker for monitoring and predicting of the oncological outcomes of colorectal cancer patients.

(Citation: Gastric & Breast Cancer 2012; 11(1) 32-34).



You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 2 January 2012